Reports
Sale
Global Intracranial Aneurysm Market Size, Trends, Analysis: By Treatment Type: Surgical Clipping, Endovascular Coiling, Flow Diverters, Others; By End User: Hospitals, Ambulatory Surgical Centers, Others; Regional Analysis; Market Dynamics: Market Drivers and Constraints, SWOT Analysis, Others; Supplier Landscape; 2024-2032
Global Intracranial Aneurysm Market Outlook
The global intracranial aneurysm market size was valued at USD 1.2 billion in 2023, driven by the rising cases of intracranial aneurysm along with the growing demand for minimally invasive procedures across the globe. The market is expected to grow at a CAGR of 8.8% during the forecast period of 2024-2032, with the values likely to rise from USD 1.3 billion in 2024 to USD 2.6 billion by 2032.
Key Takeaways
- Around 6.8 million individuals have an unruptured intracranial aneurysm in the United States, with nearly 30,000 people suffering a rupture annually.
- In May 2023, Stryker Corporation acquired Cerus Endovascular Ltd., a medical devices company specializing in neurointerventional devices to expand its neurovascular division.
- The common risk factors of intracranial aneurysms include high blood pressure, smoking, and being over 40 years of age.
Intracranial aneurysm, also known as brain aneurysm or cerebral aneurysm, is characterized by a bulge in a blood vessel in the brain. If the aneurysm leaks or ruptures, it results in bleeding in the brain called a hemorrhagic stroke. There are three types of aneurysms, saccular, fusiform, and mycotic aneurysm, out of which the saccular or berry aneurysm is the most common. To repair a ruptured aneurysm, surgery or endovascular treatment is usually required.
The intracranial aneurysm market demand is driven by the rising prevalence of the condition along with heightened patient awareness and availability of advanced treatment options. Technological innovations in diagnostic techniques are facilitating early detection of aneurysms, allowing timely intervention. Moreover, the growing demand for minimally invasive procedures and increased research and development efforts aimed at improving existing treatments and discovering novel therapeutics are anticipated to propel the market growth in the forecast period.
Global Intracranial Aneurysm Market Trends and Developments
Advancements in endovascular techniques, technological innovations, increased application of flow diverters, and growing preference for minimally invasive procedures comprise some of the key trends in the market.
| Date | Company | Event |
| December 2023 | Galaxy Therapeutics | One-year follow-up data from the PRE-SEAL IT trial, conducted to investigate various parameters such as effectiveness, safety, and feasibility of the Saccular Endovascular Aneurysm Lattice (SEAL) embolization system was presented at the Barts Research and Advanced Interventional Neuroradiology (BRAIN) conference. Developed by Galaxy Therapeutics to treat intracranial aneurysms, the one-year trial showed a 100% technical success rate, a 76.9% rate of progressive complete occlusion, and a 0% retreatment rate for the device, indicating its effectiveness in managing challenging aneurysms. |
| July 2023 | Aidoc Medical | An Israeli health technology company, Aidoc Medical, announced the launch of its artificial technology technology called Full Brain Solution. By leveraging diverse AI technologies such as image-based identification and natural language processing, it ensures holistic neurovascular care, including identification and care coordination for patients with intracranial aneurysms. This pioneering approach reduces the time to treatment by nearly half and integrates into the existing IT infrastructure via its operating system aiOS™. |
| July 2023 | RapidAI | RapidAI, a health tech company specializing in imaging analysis software, announced a USD 75 million Series C funding led by Vista Credit Partners. The company intends to utilize the funds to develop and expand its product portfolio and penetrate new markets. RapidAI has entered into cerebral aneurysm management with its FDA-cleared imaging platform (Rapid Aneurysm) to increase the detection rate and enhance the accuracy of assessment, visualization, and measurement of intracranial aneurysms. |
| May 2023 | Stryker Corporation | Stryker Corporation, a leading medical technology company, acquired Cerus Endovascular Ltd., a medical devices company specializing in neurointerventional devices for treating intracranial aneurysms. Through this partnership, Stryker has expanded its portfolio of aneurysm treatment solutions including the Cerus Endovascular’s Contour Neurovascular System and the Neqstent Coil Assisted Flow Diverter. |
| Key Trend | Impact |
| Advancements in Endovascular Techniques | Advancements in the field of endovascular surgery, including improvements in device technology, procedural techniques, and materials used for endovascular coiling and flow diversion have facilitated the treatment of a wider range of aneurysms effectively and with fewer complications as compared to traditional surgical interventions. |
| Technological Innovations | The market is witnessing a surge in technological innovations such as the advancements in imaging technologies that allow for better visualization and planning of treatments. These developments enable more personalized and effective treatment strategies, fuelling the intracranial aneurysm market demand. |
| Increased Application of Flow Diverters | Flow diverters, which redirect blood flow away from the aneurysm sac are increasingly employed to treat large or complex aneurysms. The growing preference for flow diverters indicates their success in providing a less invasive solution for aneurysms that are challenging to manage with conventional coiling techniques. |
| Growing Preference for Minimally Invasive Procedures | The rising patient inclination towards minimally invasive procedures can be attributed to their benefits in reducing recovery times and minimizing complication rates. The advancement and adoption of such procedures is driven by continuous technological innovations in medical devices, imaging techniques, and surgical tools, among others. |
Global Intracranial Aneurysm Market Growth Factors
The market is witnessing significant growth due to rising financial support from various sectors. The increased investment is primarily aimed at addressing the underlying causes of the condition, discovering new treatment options, and identifying key markers of ruptures. In September 2023, the Brain Aneurysm Foundation (BAF), granted USD 5 million in research funding to support 17 intracranial aneurysm-related research efforts. Such grants are expected to improve the treatment options available for the patients, which is likely to the augment intracranial aneurysm market value in coming years.
Technological innovations such as the integration of artificial intelligence and machine learning are increasingly employed to diagnose and manage intracranial aneurysms. These developments coupled with the expansion of healthcare access and rising awareness regarding the condition are anticipated to boost the market growth.
Global Intracranial Aneurysm Market Segmentation
“Global Intracranial Aneurysm Market Report and Forecast 2024-2032” offers a detailed analysis of the market based on the following segments:
| Market Breakup | Categories |
| Treatment Type | Surgical Clipping, Endovascular Coiling, Flow Diverters, Others |
| End User | Hospitals, Ambulatory Surgical Centres, Others |
| Region | North America, Europe, Asia Pacific, Latin America, Middle East, and Africa |
By treatment type, the market includes surgical clipping, endovascular coiling, flow diverters, and other emerging interventions. Surgical clipping is an invasive method where a clip is placed to isolate the aneurysm from the parent artery, thereby preventing rupture. Endovascular coiling is a less invasive method that involves placing a coil into the aneurysm, inducing a clot.
In terms of end-users, the intracranial aneurysm market share includes hospitals, ambulatory surgical centers, and other healthcare facilities where patients receive treatment for intracranial aneurysms.
Geographically, the market report offers insights into major regional markets including North America, Europe, Asia Pacific, Latin America, the Middle East and Africa. The regional markets are experiencing significant growth which can be attributed to the evolving regulatory policies, the growing inclination of patients towards minimally invasive procedures to treat intracranial aneurysms, and the rising emphasis on patient-centered care.
Global Intracranial Aneurysm Market: Competitive Landscape
The key market players are contributing to the intracranial aneurysm market growth through strategic partnerships, innovative product launches, and robust research and development initiatives aimed at technological advancement.
| Company | Year Founded | Headquarters | Products/Services |
| Medtronic | 1949 | Dublin, Ireland | Surgical clipping devices, endovascular coiling systems, flow diverters |
| Stryker | 1941 | Kalamazoo, Michigan, USA | Endovascular coiling systems, neurovascular stents, flow diverters |
| Shanghai MicroPort Medical (Group) Co., Ltd. | 1998 | Shanghai, China | Coil embolization systems such as Numen® Coil Embolization System and Numen FR® Coil Detachment System |
| B. Braun SE | 1839 | Melsungen, Germany | Surgical instruments for clipping (YASARGIL® Aneurysm Clips) |
Other key players in the market include Terumo Corporation, Delta Surgical, Integra LifeSciences Corporation, Mizuho Medical Co. Ltd, evonos GmbH & Co. KG, and RAUMEDIC AG.
Global Intracranial Aneurysm Market Analysis by Region
North America holds a significant share of the market due to the high prevalence rate of intracranial aneurysms in the region. Around 1 in 50 people in the United States have an unruptured brain aneurysm, with the data suggesting that a rupture happens every 18 minutes. This rising burden of the condition drives the demand for effective diagnosis and treatment strategies.
In Europe, the market growth is driven by the rising geriatric population prone to developing intracranial aneurysms. The increased patient preference towards less invasive procedures such as endovascular coils and stents as well as the presence of advanced healthcare infrastructure is expected to further fuel the market demand in the region.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Treatment Type |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Intracranial Aneurysm Market Overview
3.1 Global Intracranial Aneurysm Market Historical Value (2017-2023)
3.2 Global Intracranial Aneurysm Market Forecast Value (2024-2032)
4 Global Intracranial Aneurysm Market Landscape*
4.1 Global Intracranial Aneurysm Market: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Intracranial Aneurysm Market: Product Landscape
4.2.1 Analysis by Treatment Type
4.2.2 Analysis by Technology
5 Global Intracranial Aneurysm Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter’s Five Forces Model
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Intracranial Aneurysm Market Segmentation (2017-2032)
6.1 Global Intracranial Aneurysm Market (2017-2032) by Treatment Type
6.1.1 Market Overview
6.1.2 Surgical Clipping
6.1.3 Endovascular Coiling
6.1.4 Flow Diverters
6.1.5 Others
6.2 Global Intracranial Aneurysm Market (2017-2032) by End User
6.2.1 Market Overview
6.2.2 Hospitals
6.2.3 Ambulatory Surgical Centers
6.2.4 Others
6.3 Global Intracranial Aneurysm Market (2017-2032) by Region
6.3.1 Market Overview
6.3.2 North America
6.3.3 Europe
6.3.4 Asia Pacific
6.3.5 Latin America
6.3.6 Middle East and Africa
7 North America Intracranial Aneurysm Market (2017-2032)
7.1 North America Intracranial Aneurysm Market (2017-2032) by Treatment Type
7.1.1 Market Overview
7.1.2 Surgical Clipping
7.1.3 Endovascular Coiling
7.1.4 Flow Diverters
7.1.5 Others
7.2 North America Intracranial Aneurysm Market (2017-2032) by Country
7.2.1 United States of America
7.2.2 Canada
8 Europe Intracranial Aneurysm Market (2017-2032)
8.1 Europe Intracranial Aneurysm Market (2017-2032) by Treatment Type
8.1.1 Market Overview
8.1.2 Surgical Clipping
8.1.3 Endovascular Coiling
8.1.4 Flow Diverters
8.1.5 Others
8.2 Europe Intracranial Aneurysm Market (2017-2032) by Country
8.2.1 United Kingdom
8.2.2 Germany
8.2.3 France
8.2.4 Italy
8.2.5 Others
9 Asia Pacific Intracranial Aneurysm Market (2017-2032)
9.1 Asia Pacific Intracranial Aneurysm Market (2017-2032) by Treatment Type
9.1.1 Market Overview
9.1.2 Surgical Clipping
9.1.3 Endovascular Coiling
9.1.4 Flow Diverters
9.1.5 Others
9.2 Asia Pacific Intracranial Aneurysm Market (2017-2032) by Country
9.2.1 China
9.2.2 Japan
9.2.3 India
9.2.4 ASEAN
9.2.5 Australia
9.2.6 Others
10 Latin America Intracranial Aneurysm Market (2017-2032)
10.1 Latin America Intracranial Aneurysm Market (2017-2032) by Treatment Type
10.1.1 Market Overview
10.1.2 Surgical Clipping
10.1.3 Endovascular Coiling
10.1.4 Flow Diverters
10.1.5 Others
10.2 Latin America Intracranial Aneurysm Market (2017-2032) by Country
10.2.1 Brazil
10.2.2 Argentina
10.2.3 Mexico
10.2.4 Others
11 Middle East and Africa Intracranial Aneurysm Market (2017-2032)
11.1 Middle East and Africa Intracranial Aneurysm Market (2017-2032) by Treatment Type
11.1.1 Market Overview
11.1.2 Surgical Clipping
11.1.3 Endovascular Coiling
11.1.4 Flow Diverters
11.1.5 Others
11.2 Middle East and Africa Intracranial Aneurysm Market (2017-2032) by Country
11.2.1 Saudi Arabia
11.2.2 United Arab Emirates
11.2.3 Nigeria
11.2.4 South Africa
11.2.5 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by Year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by Departments
14.7 Analysis by Recipient Organization
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 Medtronic
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Stryker
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Shanghai MicroPort Medical (Group) Co., Ltd.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 B. Braun SE
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Terumo Corporation
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Delta Surgical
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Integra LifeSciences Corporation
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Mizuho Medical Co. Ltd
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 evonos GmbH & Co. KG
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 RAUMEDIC AG
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
List not exhaustive
18 Global Intracranial Aneurysm Market – Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
Key Questions Answered in the Report
The market attained a value of about USD 1.2 billion in 2023 driven by the rising cases of intracranial aneurysm along with the growing demand for minimally invasive procedures across the globe.
The market is anticipated to grow at a CAGR of 8.8% during the forecast period of 2024-2032, likely to reach a market value of USD 2.6 billion by 2032.
Technological innovations such as the advancements in imaging technologies and the increased healthcare expenditure are fuelling the market demand.
One of the significant trends in the market is the integration of artificial intelligence to increase detection rates of aneurysms and enhance the accuracy of assessment and visualization. In July 2023, Aidoc Medical announced the launch of its AI technology called Full Brain Solution, which ensured complete neurovascular care, including identification and care coordination for patients with intracranial aneurysms.
Based on the treatment type, the market is segmented into surgical clipping, endovascular coiling, and flow diverters, among others.
Major end users of the market include hospitals, and ambulatory surgical centers, among others.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa.
Key players involved in the market are Medtronic, Stryker, Shanghai MicroPort Medical (Group) Co., Ltd., B. Braun SE, Terumo Corporation, Delta Surgical, Integra LifeSciences Corporation, Mizuho Medical Co. Ltd, evonos GmbH & Co. KG, and RAUMEDIC AG.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER